Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors

被引：17

作者：

Miles, Dillon H. ^{[1
]}

Yan, Xuelei ^{[1
]}

Thomas-Tran, Rhiannon ^{[1
]}

Fournier, Jeremy ^{[1
]}

Sharif, Ehesan U. ^{[1
]}

Drew, Samuel L. ^{[1
]}

Mata, Guillaume ^{[1
]}

Lawson, Kenneth, V ^{[1
]}

Ginn, Elaine ^{[1
]}

Wong, Kent ^{[1
]}

Soni, Divyank ^{[1
]}

Dhanota, Puja ^{[1
]}

Shaqfeh, Stefan G. ^{[1
]}

Meleza, Cesar ^{[1
]}

Chen, Ada ^{[1
]}

Pham, Amber T. ^{[1
]}

Park, Timothy ^{[1
]}

Swinarski, Debbie ^{[1
]}

Banuelos, Jesus ^{[1
]}

Schindler, Ulrike ^{[1
]}

Walters, Matthew J. ^{[1
]}

Walker, Nigel P. ^{[1
]}

Zhao, Xiaoning ^{[1
]}

Young, Stephen W. ^{[1
]}

Chen, Jie ^{[1
]}

Jin, Lixia ^{[1
]}

Leleti, Manmohan Reddy ^{[1
]}

Powers, Jay P. ^{[1
]}

Jeffrey, Jenna L. ^{[1
]}

机构：

[1] Arcus Biosci Inc, Hayward, CA 94545 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2020年 / 11卷 / 11期

关键词：

PI3K gamma; inhibitor; selective; azaindole; immunomodulation; cancer;

D O I：

10.1021/acsmedchemlett.0c00387

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The successful application of immunotherapy in the treatment of cancer relies on effective engagement of immune cells in the tumor microenvironment. Phosphoinositide 3-kinase gamma (PI3K gamma) is highly expressed in tumor-associated macrophages, and its expression levels are associated with tumor immunosuppression and growth. Selective inhibition of PI3K gamma offers a promising strategy in immunooncology, which has led to the development of numerous potent PI3K gamma inhibitors with variable selectivity profiles. To facilitate further investigation of the therapeutic potential of PI3K gamma inhibition, we required a potent and PI3K gamma-selective tool compound with sufficient metabolic stability for use in future in vivo studies. Herein, we describe some of our efforts to realize this goal through the systematic study of SARs within a series of 7-azaindole-based PI3K gamma inhibitors. The large volume of data generated from this study helped guide our subsequent lead optimization efforts and will inform further development of PI3K gamma-selective inhibitors for use in immunomodulation.

引用

页码：2244 / 2252

页数：9

共 50 条

[41] Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties
Hoegenauer, Klemens
Soldermann, Nicolas
Hebach, Christina
Hollingworth, Gregory J.
Lewis, Ian
von Matt, Anette
Smith, Alexander B.
Wolf, Romain M.
Wilcken, Rainer
Haasen, Dorothea
Burkhart, Christoph
Zecri, Frederic
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (23) : 5657 - 5662
[42] Discovery of a Potent, Selective, and Orally Available PI3Kδ Inhibitor for the Treatment of Inflammatory Diseases
Erra, Montse
Taltavull, Joan
Greco, Angelique
Javier Bernal, Francisco
Francisco Caturla, Juan
Gracia, Jordi
Dominguez, Maria
Sabate, Mar
Paris, Stephane
Soria, Salome
Hernandez, Begona
Armengol, Clara
Cabedo, Judit
Bravo, Monica
Calama, Elena
Miralpeix, Montserrat
Lehner, Martin D.
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (01): : 118 - 123
[43] Discovery of AZD8835, a potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of PIK3CA-dependent cancers
Barlaam, Bernard
Cosulich, Sabina
Delouvrie, Benedicte
Fitzek, Martina
Germain, Herve
Green, Stephen
Harris, Craig S.
Hudson, Kevin
Lambert-van der Brempt, Christine
Lamorlette, Maryannick
Antoine, Le Griffon
Morgentin, Remy
Ouvry, Gilles
Page, Ken
Pasquet, Georges
Ruston, Linette
Saleh, Twana
Vautier, Michel
Ward, Lara
CANCER RESEARCH, 2015, 75
[44] Discovery of novel and highly selective PI3Kδ inhibitors based on the p110δ crystal structure
Jia, Wen-Qing
Liu, Ya-Ya
Feng, Xiao-Yan
Xu, Wei-Ren
Cheng, Xian-Chao
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (08): : 2499 - 2508
[45] Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors
Hoegenauer, Klemens
Soldermann, Nicolas
Stauffer, Frederic
Furet, Pascal
Graveleau, Nadege
Smith, Alexander B.
Hebach, Christina
Hollingworth, Gregory J.
Lewis, Ian
Gutmann, Sascha
Rummel, Gabriele
Knapp, Mark
Wolf, Romain M.
Blanz, Joachim
Feifel, Roland
Burkhart, Christoph
Zecri, Frederic
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (08): : 762 - 767
[46] Discovery of a novel series of potent and selective Phosphatidylinositol-3-Kinase delta (PI3Kδ) inhibitors for the treatment of inflammatory and autoimmune diseases
Aguilar, Nuria
Carles Fernandez, Joan
Hernandez, Begona
Carrascal, Marta
Nino, Patricia
Lopez, Alba
Vazquez, Laura
Lozoya, Estrella
Maldonado, Monica
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[47] Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors
de Turiso, Felix Gonzalez-Lopez
Shin, Youngsook
Brown, Matthew
Cardozo, Mario
Chen, Yi
Fong, David
Hao, Xiaolin
He, Xiao
Henne, Kirk
Hu, Yi-Ling
Johnson, Michael G.
Kohn, Todd
Lohman, Julia
McBride, Helen J.
McGee, Lawrence R.
Medina, Julio C.
Metz, Daniela
Miner, Kent
Mohn, Deanna
Pattaropong, Vatee
Seganish, Jennifer
Simard, Jillian L.
Wannberg, Sharon
Whittington, Douglas A.
Yu, Gang
Cushing, Timothy D.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (17) : 7667 - 7685
[48] Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors
Hamajima, Toshihiro
Takahashi, Fumie
Kato, Koji
Mukoyoshi, Koichiro
Yoshihara, Kousei
Yamaki, Susumu
Sugano, Yukihito
Moritomo, Ayako
Yamagami, Kaoru
Yokoo, Koji
Fukahori, Hidehiko
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (09) : 2410 - 2419
[49] Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα
Nacht, Mariana
Qiao, Lixin
Sheets, Michael P.
St. Martin, Thia
Labenski, Matthew
Mazdiyasni, Hormoz
Karp, Russell
Zhu, Zhendong
Chaturvedi, Prasoon
Bhavsar, Deepa
Niu, Deqiang
Westlin, William
Petter, Russell C.
Medikonda, Aravind Prasad
Singh, Juswinder
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) : 712 - 721
[50] Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kβ) inhibitors with selectivity over PI3Kα
Kim, Jinhee
Hong, Seunghee
Hong, Sungwoo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 6977 - 6981

← 1 2 3 4 5 →